missing translation for 'onlineSavingsMsg'
Learn More

PeproTech IL-31 Polyclonal Antibody, PeproTech®, Invitrogen™

Rabbit Polyclonal Antibody

£177.00 - £1468.00

Specifications

Antigen IL-31
Concentration 0.1-1.0 mg/mL
Applications ELISA, Western Blot
Classification Polyclonal
Conjugate Unconjugated
View More Specs

Products 3
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17864873
View Documents
PeproTech
500-P249-50UG
50 μg
£177.00
50µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
17875583
View Documents
PeproTech
500-P249-100UG
100 μg
£228.00
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
17885503
View Documents
PeproTech
500-P249-1MG
1 mg
£1468.00
1mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

AA Sequence of recombinant protein: SHTLPVRLLR PSDDVQKIVE ELQSLSKMLL KDVEEEKGVL VSQNYTLPCL SPDAQPPNNI HSPAIRAYLK TIRQLDNKSV IDEIIEHLDK LIFQDAPETN ISVPTDTHEC KRFILTISQQ FSECMDLALK SLTSGAQQAT T. Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human IL-31. Anti-Human IL-31-specific antibody was purified by affinity chromatography employing an immobilized Human IL-31 matrix. Sandwich ELISA: To detect Human IL-31 by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.5-2.0 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech Biotinylated Anti-Human IL-31 (500-P249Bt) as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of Recombinant Human IL-31. Western Blot: To detect Human IL-31 by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for Recombinant Human IL-31 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.
Specifications

Specifications

IL-31
ELISA, Western Blot
Unconjugated
Rabbit
Human
Q6EBC2
386653
E.coli-derived Recombinant Human IL-31.
Antigen affinity chromatography
Il31
0.1-1.0 mg/mL
Polyclonal
Lyophilized
RUO
PBS with no preservative
1700013B14Rik; IL31; IL-31; ILN; Interleukin; interleukin 31; interleukin-31
Il31
Primary
-20°C
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.